65 related articles for article (PubMed ID: 21685522)
1. [Effect of leptin on bone mineral dencity in premenopausal and postmenopausal women].
Shanava Sh; Zerekidze T; Amashukeli M; Asatiani Q
Georgian Med News; 2011 May; (194):47-52. PubMed ID: 21685522
[TBL] [Abstract][Full Text] [Related]
2. Action of leptin on bone and its relationship to menopause.
Petzel M
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2007 Dec; 151(2):195-9. PubMed ID: 18345251
[TBL] [Abstract][Full Text] [Related]
3. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.
De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C
Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627
[TBL] [Abstract][Full Text] [Related]
4. Effects of low-dose continuous combined conjugated estrogens and medroxyprogesterone acetate on menopausal symptoms, body weight, bone density, and metabolism in postmenopausal women.
Gambacciani M; Ciaponi M; Cappagli B; Genazzani AR
Am J Obstet Gynecol; 2001 Nov; 185(5):1180-5. PubMed ID: 11717654
[TBL] [Abstract][Full Text] [Related]
5. Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables.
Jürimäe J; Jürimäe T
Am J Physiol Endocrinol Metab; 2007 Jul; 293(1):E42-7. PubMed ID: 17341545
[TBL] [Abstract][Full Text] [Related]
6. Relationships between serum leptin level and regional bone mineral density, bone metabolic markers in healthy women.
Iwamoto I; Douchi T; Kosha S; Murakami M; Fujino T; Nagata Y
Acta Obstet Gynecol Scand; 2000 Dec; 79(12):1060-4. PubMed ID: 11130088
[TBL] [Abstract][Full Text] [Related]
7. The changes in circulating osteoprotegerin after hormone therapy in postmenopausal women and their relationship with oestrogen responsiveness on bone.
Han KO; Choi JT; Choi HA; Moon IG; Yim CH; Park WK; Yoon HK; Han IK
Clin Endocrinol (Oxf); 2005 Mar; 62(3):349-53. PubMed ID: 15730418
[TBL] [Abstract][Full Text] [Related]
8. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women.
Ushiroyama T; Ikeda A; Hosotani T; Higashiyama T; Ueki M
Gynecol Endocrinol; 2003 Feb; 17(1):31-6. PubMed ID: 12724016
[TBL] [Abstract][Full Text] [Related]
9. [Absence of antiosteopenic effect of hormone replacement therapy in postmenopausal women].
Ortiz Núñez DA; Mengchún López G; Hernández Marín I; Mendoza R; Ayala Ruíz AR
Ginecol Obstet Mex; 2004 Jul; 72():349-55. PubMed ID: 15469174
[TBL] [Abstract][Full Text] [Related]
10. Differential effects of teriparatide and alendronate on bone remodeling in postmenopausal women assessed by histomorphometric parameters.
Arlot M; Meunier PJ; Boivin G; Haddock L; Tamayo J; Correa-Rotter R; Jasqui S; Donley DW; Dalsky GP; Martin JS; Eriksen EF
J Bone Miner Res; 2005 Jul; 20(7):1244-53. PubMed ID: 15940379
[TBL] [Abstract][Full Text] [Related]
11. Influence of obesity and menopausal status on serum leptin, cholecystokinin, galanin and neuropeptide Y levels.
Milewicz A; Bidzińska B; Mikulski E; Demissie M; Tworowska U
Gynecol Endocrinol; 2000 Jun; 14(3):196-203. PubMed ID: 10923281
[TBL] [Abstract][Full Text] [Related]
12. Role of ovarian hormones in the regulation of protein metabolism in women: effects of menopausal status and hormone replacement therapy.
Toth MJ; Sites CK; Matthews DE
Am J Physiol Endocrinol Metab; 2006 Sep; 291(3):E639-46. PubMed ID: 16684855
[TBL] [Abstract][Full Text] [Related]
13. Abdominal fat distribution in pre- and postmenopausal women: The impact of physical activity, age, and menopausal status.
Kanaley JA; Sames C; Swisher L; Swick AG; Ploutz-Snyder LL; Steppan CM; Sagendorf KS; Feiglin D; Jaynes EB; Meyer RA; Weinstock RS
Metabolism; 2001 Aug; 50(8):976-82. PubMed ID: 11474488
[TBL] [Abstract][Full Text] [Related]
14. Is leptin the link between fat and bone mass?
Thomas T; Burguera B
J Bone Miner Res; 2002 Sep; 17(9):1563-9. PubMed ID: 12211425
[TBL] [Abstract][Full Text] [Related]
15. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women.
Kontogianni MD; Dafni UG; Routsias JG; Skopouli FN
J Bone Miner Res; 2004 Apr; 19(4):546-51. PubMed ID: 15005840
[TBL] [Abstract][Full Text] [Related]
16. The complex effects of leptin on bone metabolism through multiple pathways.
Thomas T
Curr Opin Pharmacol; 2004 Jun; 4(3):295-300. PubMed ID: 15140423
[TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study.
Jensen LB; Vestergaard P; Hermann AP; Gram J; Eiken P; Abrahamsen B; Brot C; Kolthoff N; Sørensen OH; Beck-Nielsen H; Nielsen SP; Charles P; Mosekilde L
J Bone Miner Res; 2003 Feb; 18(2):333-42. PubMed ID: 12568411
[TBL] [Abstract][Full Text] [Related]
18. Effect of oestrogen replacement therapy on bone mass in post-menopausal Bangladeshi women.
Begum F; Shamsuddin L; Hussain MA; Chowdhury TA; Rahman M; Das TR
Bangladesh Med Res Counc Bull; 2001 Dec; 27(3):103-11. PubMed ID: 12197624
[TBL] [Abstract][Full Text] [Related]
19. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
Garnero P; Sornay-Rendu E; Chapuy MC; Delmas PD
J Bone Miner Res; 1996 Mar; 11(3):337-49. PubMed ID: 8852944
[TBL] [Abstract][Full Text] [Related]
20. [The risk factors and bone mineral density in women on long-term levothyroxine treatment].
López Alvarez MB; Hawkins F; Rigopoulou D; Martínez G; Jodar E; Estenoz J; Ortuño B; Arnaiz F
Med Clin (Barc); 1999 Jan; 112(3):85-9. PubMed ID: 10074614
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
